KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 97 filers reported holding KRONOS BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,687,347 | -24.4% | 1,297,959 | 0.0% | 0.68% | -20.2% |
| Q2 2023 | $2,232,489 | +17.8% | 1,297,959 | 0.0% | 0.85% | +20.7% |
| Q1 2023 | $1,895,020 | -18.7% | 1,297,959 | -9.8% | 0.70% | -20.9% |
| Q4 2022 | $2,329,936 | -51.6% | 1,438,232 | 0.0% | 0.89% | -51.9% |
| Q3 2022 | $4,818,000 | -8.0% | 1,438,232 | 0.0% | 1.85% | +6.7% |
| Q2 2022 | $5,235,000 | -49.7% | 1,438,232 | 0.0% | 1.73% | -34.8% |
| Q1 2022 | $10,398,000 | -46.8% | 1,438,232 | 0.0% | 2.66% | -16.4% |
| Q4 2021 | $19,546,000 | -35.2% | 1,438,232 | 0.0% | 3.18% | -18.4% |
| Q3 2021 | $30,145,000 | -12.5% | 1,438,232 | 0.0% | 3.90% | -0.2% |
| Q2 2021 | $34,446,000 | -18.2% | 1,438,232 | 0.0% | 3.91% | -24.0% |
| Q1 2021 | $42,097,000 | -2.0% | 1,438,232 | 0.0% | 5.14% | -4.8% |
| Q4 2020 | $42,960,000 | – | 1,438,232 | – | 5.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $57,961,000 | 16.60% |
| Omega Fund Management, LLC | 3,818,283 | $80,031,000 | 8.98% |
| Wildcat Capital Management, LLC | 1,438,232 | $30,145,000 | 3.90% |
| COMMODORE CAPITAL LP | 298,839 | $6,264,000 | 1.65% |
| Perceptive Advisors | 2,421,142 | $50,747,000 | 0.74% |
| Alphabet Inc. | 1,438,232 | $30,145,000 | 0.72% |
| Artal Group S.A. | 1,317,954 | $27,624,000 | 0.62% |
| Choate Investment Advisors | 393,436 | $8,246,000 | 0.53% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $11,056,000 | 0.51% |
| Coastal Bridge Advisors, LLC | 78,635 | $1,648,000 | 0.38% |